Profile
Marie A. Lindner was the founder of Embera NeuroTherapeutics, Inc. founded in 2005, where she held the title of Director & Medical Monitor.
Currently, she is an Independent Director at Orthogon Therapeutics LLC, Giiant Pharma, Inc., BioCurate Pty Ltd., and a Scientific Advisor at FutuRx Ltd. In the past, she held senior positions at Shire Pharmaceuticals, Inc., Rhône-Poulenc, Inc., GlaxoSmithKline LLC, Trino Therapeutics Ltd., Fibrocell Science, Inc., Elan Drug Delivery, Inc., Novartis AG, BTG Ltd., The Biotechnology Greenhouse Corp.
of Southeastern PA, BTG International, Inc., and Elan Corp.
She has also earned an undergraduate degree from Washington University in St. Louis and a graduate degree from Rosalind Franklin University of Medicine & Science.
Marie Lindner active positions
| Companies | Position | Start |
|---|---|---|
Giiant Pharma, Inc.
Giiant Pharma, Inc. BiotechnologyHealth Technology Operates as preclinical-stage biotech company | Director/Board Member | - |
Orthogon Therapeutics LLC
Orthogon Therapeutics LLC Pharmaceuticals: MajorHealth Technology Provides drug development solutions | Director/Board Member | 2021-11-14 |
BioCurate Pty Ltd.
BioCurate Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug development company | Director/Board Member | - |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Consultant / Advisor | - |
Former positions of Marie Lindner
| Companies | Position | End |
|---|---|---|
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Private Equity Investor | 2012-06-30 |
| FIBROCELL SCIENCE, INC. | Corporate Officer/Principal | 2006-12-30 |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Corporate Officer/Principal | - |
Elan Drug Delivery, Inc.
Elan Drug Delivery, Inc. Pharmaceuticals: MajorHealth Technology Engaged in manufacturing, fabricating, or processing drugs in pharmaceutical preparations for human or veterinary use | Corporate Officer/Principal | 2002-12-30 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Director/Board Member | 1999-12-30 |
Training of Marie Lindner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fibrocell Science, Inc.
Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Elan Drug Delivery, Inc.
Elan Drug Delivery, Inc. Pharmaceuticals: MajorHealth Technology Engaged in manufacturing, fabricating, or processing drugs in pharmaceutical preparations for human or veterinary use | Health Technology |
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for smoking cessation, cocaine dependence and other addictions | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Finance |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
Rosalind Franklin University of Medicine & Science
Rosalind Franklin University of Medicine & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rhône-Poulenc, Inc. | Process Industries |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Elan Corp.
Elan Corp. Pharmaceuticals: MajorHealth Technology Engages in the nursing care business | Health Technology |
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug discovery and development company | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
Orthogon Therapeutics LLC
Orthogon Therapeutics LLC Pharmaceuticals: MajorHealth Technology Provides drug development solutions | Health Technology |
Giiant Pharma, Inc.
Giiant Pharma, Inc. BiotechnologyHealth Technology Operates as preclinical-stage biotech company | Health Technology |
BioCurate Pty Ltd.
BioCurate Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug development company | Health Technology |
- Stock Market
- Insiders
- Marie Lindner
















